Allspring Global Investments Holdings LLC Trims Stock Holdings in Doximity, Inc. $DOCS

Allspring Global Investments Holdings LLC cut its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 1.5% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 17,078 shares of the company’s stock after selling 255 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Doximity were worth $997,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. grew its position in shares of Doximity by 8.8% during the first quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company’s stock worth $707,646,000 after buying an additional 990,923 shares in the last quarter. Invesco Ltd. boosted its stake in Doximity by 54.8% during the 1st quarter. Invesco Ltd. now owns 1,969,326 shares of the company’s stock valued at $114,280,000 after acquiring an additional 696,923 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Doximity by 130.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company’s stock worth $114,133,000 after acquiring an additional 1,113,076 shares in the last quarter. Fuller & Thaler Asset Management Inc. increased its position in shares of Doximity by 9.5% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 1,730,282 shares of the company’s stock worth $100,408,000 after purchasing an additional 150,574 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its stake in shares of Doximity by 8.2% in the 1st quarter. Bank of New York Mellon Corp now owns 1,137,912 shares of the company’s stock valued at $66,033,000 after purchasing an additional 86,135 shares in the last quarter. 87.19% of the stock is owned by institutional investors and hedge funds.

Doximity Trading Down 2.3%

Shares of NASDAQ DOCS opened at $66.33 on Thursday. Doximity, Inc. has a 12-month low of $40.87 and a 12-month high of $85.21. The company has a market cap of $12.42 billion, a PE ratio of 66.33, a P/E/G ratio of 4.10 and a beta of 1.38. The stock has a 50 day simple moving average of $69.51 and a 200-day simple moving average of $61.52.

Doximity (NASDAQ:DOCS) last posted its earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period in the previous year, the company posted $0.28 EPS. The company’s revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Sell-side analysts forecast that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Insider Buying and Selling at Doximity

In other news, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction on Friday, August 1st. The stock was sold at an average price of $57.09, for a total value of $114,180.00. Following the sale, the director owned 16,618 shares of the company’s stock, valued at approximately $948,721.62. The trade was a 10.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Regina M. Benjamin sold 5,000 shares of the firm’s stock in a transaction dated Friday, October 10th. The shares were sold at an average price of $70.84, for a total value of $354,200.00. Following the transaction, the director directly owned 19,839 shares of the company’s stock, valued at $1,405,394.76. This represents a 20.13% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 37,000 shares of company stock valued at $2,635,880. Company insiders own 31.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on DOCS shares. Robert W. Baird boosted their price objective on Doximity from $75.00 to $80.00 and gave the company an “outperform” rating in a report on Thursday, September 11th. Wells Fargo & Company lifted their target price on Doximity from $55.00 to $62.00 and gave the stock an “equal weight” rating in a research report on Monday, August 4th. Needham & Company LLC upped their price target on Doximity from $67.00 to $75.00 and gave the company a “buy” rating in a research report on Friday, August 8th. JPMorgan Chase & Co. restated an “underweight” rating and set a $62.00 price objective on shares of Doximity in a research note on Friday, October 10th. Finally, Canaccord Genuity Group boosted their target price on shares of Doximity from $59.00 to $67.00 and gave the company a “hold” rating in a research note on Thursday, September 18th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $69.37.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.